Skip to main content
Screener/Healthcare/Biotechnology

ARQT — Arcutis Biotherapeutics, Inc.

NASDAQ
$24.92+1.43 (+6.06%)
Mid CapUnder $50HealthcareFastest GrowingHigh Beta
$16.57
$31.77
$23.63
$25.62
EPS (TTM)$-0.03
P/E Ratio-185.06
Dividend Yield—
Market Cap$2.99B
Volume2.79M
Prev Close$23.51
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$105.4M-$11.3M$-0.0990.7%-10.7%
Q4 '25$129.5M$17.4M$0.1391.0%13.4%
Q3 '25$99.2M$7.4M$0.0691.2%7.5%
Q2 '25$81.5M-$15.9M$-0.1390.8%-19.5%
Q1 '25$65.8M-$25.1M$-0.2086.6%-38.1%
Q4 '24$71.4M-$10.8M$-0.0990.3%-15.1%
Q3 '24$44.8M-$41.5M$-0.3387.7%-92.8%
Q2 '24$30.9M-$52.3M$-0.4288.8%-169.6%
Get Your Daily Market Recap